- Home
- RCKT vs VVX Comparison
RCKT vs VVX Comparison
Compare RCKT & VVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCKT
- VVX
- Stock Information
- Founded
- RCKT 1999
- VVX 2014
- Country
- RCKT United States
- VVX United States
- Employees
- RCKT 299
- VVX N/A
- Industry
- RCKT Biotechnology: Pharmaceutical Preparations
- VVX Diversified Commercial Services
- Sector
- RCKT Health Care
- VVX Consumer Discretionary
- Exchange
- RCKT Nasdaq
- VVX Nasdaq
- Market Cap
- RCKT 264.0M
- VVX 1.4B
- IPO Year
- RCKT N/A
- VVX 2014
- Fundamental
- Price
- RCKT $2.81
- VVX $49.66
- Analyst Decision
- RCKT Buy
- VVX Buy
- Analyst Count
- RCKT 13
- VVX 9
- Target Price
- RCKT $18.50
- VVX $64.11
- AVG Volume (30 Days)
- RCKT 4.2M
- VVX 241.6K
- Earning Date
- RCKT 08-04-2025
- VVX 08-05-2025
- Dividend Yield
- RCKT N/A
- VVX N/A
- EPS Growth
- RCKT N/A
- VVX N/A
- EPS
- RCKT N/A
- VVX 1.29
- Revenue
- RCKT N/A
- VVX $4,327,514,000.00
- Revenue This Year
- RCKT N/A
- VVX $4.02
- Revenue Next Year
- RCKT N/A
- VVX $4.80
- P/E Ratio
- RCKT N/A
- VVX $38.43
- Revenue Growth
- RCKT N/A
- VVX 7.38
- 52 Week Low
- RCKT $2.19
- VVX $41.08
- 52 Week High
- RCKT $26.98
- VVX $69.75
- Technical
- Relative Strength Index (RSI)
- RCKT 40.19
- VVX 67.03
- Support Level
- RCKT $2.40
- VVX $47.73
- Resistance Level
- RCKT $2.96
- VVX $50.25
- Average True Range (ATR)
- RCKT 0.21
- VVX 1.27
- MACD
- RCKT 0.15
- VVX 0.55
- Stochastic Oscillator
- RCKT 61.65
- VVX 90.92
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.
About VVX V2X Inc.
V2X Inc is a U.S.-based company that provides services to the U.S. government. It operates as one segment and offers facility and logistics services and information technology mission support and engineering and digital integration services. The information technology and network communications capabilities consist of communications systems operations and maintenance, management and service support, systems installation and activation, system-of-systems engineering and software development, and mission support for the department of defense. The facility and logistics service include airfield management, ammunition management, civil engineering, communications, emergency services, life support activities, public works, security, transportation operations, and others.